- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 13, 2026 | 11.12M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 10.24M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 6.54M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 440.15K sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 413.62K sh |
| Capex | Q2 2026 · Mar 31, 2026 | $336.78K |
| Capex | Q2 2026 · Mar 31, 2025 | $1.36M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$5.31M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $1.6M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $8.76M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $4.59M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $6.57M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $4.97M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $4.54M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $34.71M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $29.09M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $8.72M |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2025 | $6.73M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | −$1.56M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $4.71M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $24.22M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $23.82M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $36.03M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $39.07M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $37.93M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $29.01M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $70.74M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $47.79M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $7.96M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $15.56M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $6.46M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $13.22M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $546.86K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $1.05M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $777.89K |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $1.67M |
| Net Income | Q2 2026 · Mar 31, 2026 | $907.05K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$19.65M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$20.56M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$28.11M |
| Net Income restated | Q2 2026 · Mar 31, 2025 | $8.64M |
| Net Income restated | Q2 2026 · Mar 31, 2025 | −$20.12M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$28.75M |
| Net Income restated | Q2 2026 · Sep 30, 2024 | −$7.23M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$2.17M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$4.98M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $4.62M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $2.34M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $6.85M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $12.47M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $12.17M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $17.87M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $11.21M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $21.73M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $15.08M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $23.12M |
| Revenue | Q2 2026 · Mar 31, 2026 | $18.06M |
| Revenue | Q2 2026 · Mar 31, 2026 | $34.19M |
| Revenue | Q2 2026 · Mar 31, 2025 | $27.25M |
| Revenue | Q2 2026 · Mar 31, 2025 | $40.99M |